Health Care Reform To Loosen Control On Doctors
This article was originally published in PharmAsia News
Executive Summary
China's health care reform plan is still in the process of getting input and undergoing adjustments. A recent seminar on new health care reform and industry development discussed the domestic hospital management system; proposals that doctors could become independent professionals and register at multiple sites or hospitals may be adopted by the reform plan. Informed sources revealed that the previous two meetings held by the State Council also proposed actively looking into the reasonable flow of doctors. However, legislators worry that liberalizing policies could compromise the supervision of medical practice and increase the risks of unwanted incidents. A Ministry of Health official says the reform will need to include systems for medical accountability and social insurance, requiring different related policies to be developed. (Click here for more - Chinese Language)
You may also be interested in...
Prestige Expands UK Eye Care Range In Response To Consumer Demand
A “great consumer response” to TheraTears in the UK leads Prestige Consumer Healthcare to add TheraTears 5-in-1 Irritation and Redness eye drops to the range.
Who’s Hired? Hikma Recruits New US Generics President
A flurry of top level recruitments made headlines in the past weeks, with the likes of Hikma, Lupin, and Viatris announcing new hires while focusing on their targets for the year.
Organon And Henlius Complete Phase III For Denosumab
Having earlier this year reported positive Phase I data for their partnered denosumab biosimilar candidate, Organon and Shanghai Henlius Biotech have now announced that their HLX14 version has met primary endpoints in a Phase III study.